Moriarty, Natassja and Attar, Nadeem (2020) Clenbuterol-Induced Myocarditis: A Case Report. European Journal of Case Reports in Internal Medicine, 7 (9). pp. 1-4. ISSN ISSN: 2284-2594
|
Text
1662-Article Text-14503-1-10-20200619.pdf - Published Version Download (278kB) | Preview |
Abstract
Objective: We present a case of a 22-year-old bodybuilder diagnosed with myocarditis secondary to clenbuterol use. Results: The patient was primarily managed conservatively by the discontinuation of clenbuterol and the temporary use of dual anti-platelets, beta-blockers and nitrates.Conclusion: Clenbuterol is a long-acting beta-2 agonist primarily used in veterinary medicine. In recent years, it has been illegally marketed as a weight loss supplement because of its anabolic properties and is popular among fitness enthusiasts. It is our aim to use this case to underscore the adverse effects of this drug with hopes that tighter regulations will be instituted to stem its illegal distribution.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Clenbuterol, myocardial infarction |
| Subjects: | 600 Tecnologia - Scienze applicate 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
| Depositing User: | Marina Spanti |
| Date Deposited: | 15 Dec 2021 13:17 |
| Last Modified: | 15 Dec 2021 13:17 |
| URI: | http://eprints.bice.rm.cnr.it/id/eprint/20997 |
Actions (login required)
 |
View Item |
